Related Experiment Video
Updated: Feb 11, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Non-coding RNAs as biomarkers for acute myocardial infarction
1Key Laboratory of Stem Cell Biology, Institute of Health Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & Shanghai Jiao-Tong University School of Medicine, Shanghai, China, 200031.
Circulating non-coding RNAs show promise as biomarkers for early diagnosis and prognosis of acute myocardial infarction (AMI). These molecules offer a new avenue for personalized medicine and improved patient outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Medicine
Background:
- Acute myocardial infarction (AMI) poses a significant global health threat, necessitating early and accurate diagnosis for improved patient outcomes.
- Circulating non-coding RNAs have emerged as potential biomarkers for various diseases, including cardiovascular conditions.
- Specific microRNAs (e.g., miR-208a, miR-1, miR-499, miR-133) have been identified in circulation and linked to AMI diagnosis and prognosis.
Purpose of the Study:
- To summarize recent findings on non-coding RNAs as biomarkers for the early diagnosis and monitoring of ST-segment elevation myocardial infarction (STEMI).
- To explore the prognostic potential of circulating non-coding RNAs in patients undergoing percutaneous coronary intervention.
- To highlight the development of a miRNA release spectrum for quantitative, time-lapse monitoring of AMI progression and personalized medical care.
Main Methods:
- Literature review of studies investigating non-coding RNAs in AMI.
- Analysis of data from biobank studies.
- Construction of a circulating non-coding RNA network for diagnostic information.
Main Results:
- Non-coding RNAs serve as effective biomarkers for both the diagnosis and prognosis of AMI.
- A miRNA release spectrum allows for quantitative and time-lapse monitoring of AMI progression.
- Circulating non-coding RNA networks provide high specificity and sensitivity for detailed diagnostic information.
Conclusions:
- Circulating non-coding RNAs represent a promising tool for the early diagnosis, prognosis, and personalized monitoring of AMI.
- The development of miRNA release spectrums and networks facilitates customized medical care and potentially revolutionizes clinical diagnosis.
- Further research into the roles and kinetics of circulating non-coding RNAs could transform cardiovascular disease management.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
piRNA - Piwi-interacting RNAs
Nursing Code of Ethics
Small interfering RNAs (siRNA)

